These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 28137305)

  • 1. Peripheral apoE isoform levels in cognitively normal APOE ε3/ε4 individuals are associated with regional gray matter volume and cerebral glucose metabolism.
    Nielsen HM; Chen K; Lee W; Chen Y; Bauer RJ; Reiman E; Caselli R; Bu G
    Alzheimers Res Ther; 2017 Jan; 9(1):5. PubMed ID: 28137305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma Apolipoprotein E3 and Glucose Levels Are Associated in APOE ɛ3/ɛ4 Carriers.
    Edlund AK; Chen K; Lee W; Protas H; Su Y; Reiman E; Caselli R; Nielsen HM
    J Alzheimers Dis; 2021; 81(1):339-354. PubMed ID: 33814450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
    Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
    Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypometabolism in Alzheimer-affected brain regions in cognitively healthy Latino individuals carrying the apolipoprotein E epsilon4 allele.
    Langbaum JB; Chen K; Caselli RJ; Lee W; Reschke C; Bandy D; Alexander GE; Burns CM; Kaszniak AW; Reeder SA; Corneveaux JJ; Allen AN; Pruzin J; Huentelman MJ; Fleisher AS; Reiman EM
    Arch Neurol; 2010 Apr; 67(4):462-8. PubMed ID: 20385913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.
    Knopman DS; Jack CR; Wiste HJ; Lundt ES; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Roberts RO; Boeve BF; Petersen RC
    Neurobiol Aging; 2014 Sep; 35(9):2096-106. PubMed ID: 24702820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlations between FDG PET glucose uptake-MRI gray matter volume scores and apolipoprotein E ε4 gene dose in cognitively normal adults: a cross-validation study using voxel-based multi-modal partial least squares.
    Chen K; Ayutyanont N; Langbaum JB; Fleisher AS; Reschke C; Lee W; Liu X; Alexander GE; Bandy D; Caselli RJ; Reiman EM
    Neuroimage; 2012 May; 60(4):2316-22. PubMed ID: 22348880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation on brain gray matter activity and white matter integrity by APOE ε4 risk gene in cognitively intact elderly: A multimodal neuroimaging study.
    Cai S; Jiang Y; Wang Y; Wu X; Ren J; Lee MS; Lee S; Huang L
    Behav Brain Res; 2017 Mar; 322(Pt A):100-109. PubMed ID: 28108320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular risk in cognitively preserved elderlies is associated with glucose hypometabolism in the posterior cingulate cortex and precuneus regardless of brain atrophy and apolipoprotein gene variations.
    Tamashiro-Duran JH; Squarzoni P; de Souza Duran FL; Curiati PK; Vallada HP; Buchpiguel CA; Lotufo PA; Wajngarten M; Menezes PR; Scazufca M; de Toledo Ferraz Alves TC; Busatto GF
    Age (Dordr); 2013 Jun; 35(3):777-92. PubMed ID: 22544617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction Between BDNF Val66Met and APOE4 on Biomarkers of Alzheimer's Disease and Cognitive Decline.
    Stonnington CM; Velgos SN; Chen Y; Syed S; Huentelman M; Thiyyagura P; Lee W; Richholt R; Caselli RJ; Locke DEC; Lu B; Reiman EM; Su Y; Chen K
    J Alzheimers Dis; 2020; 78(2):721-734. PubMed ID: 33044176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of sex and APOE ε4 with brain tau deposition and atrophy in older adults with Alzheimer's disease.
    Yan S; Zheng C; Paranjpe MD; Li J; Benzinger TLS; Lu J; Zhou Y
    Theranostics; 2020; 10(23):10563-10572. PubMed ID: 32929366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human apolipoprotein E isoforms differentially affect bone mass and turnover in vivo.
    Dieckmann M; Beil FT; Mueller B; Bartelt A; Marshall RP; Koehne T; Amling M; Ruether W; Cooper JA; Humphries SE; Herz J; Niemeier A
    J Bone Miner Res; 2013 Feb; 28(2):236-45. PubMed ID: 22991192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex modifies APOE ε4 dose effect on brain tau deposition in cognitively impaired individuals.
    Yan S; Zheng C; Paranjpe MD; Li Y; Li W; Wang X; Benzinger TLS; Lu J; Zhou Y
    Brain; 2021 Nov; 144(10):3201-3211. PubMed ID: 33876815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher serum total cholesterol levels in late middle age are associated with glucose hypometabolism in brain regions affected by Alzheimer's disease and normal aging.
    Reiman EM; Chen K; Langbaum JB; Lee W; Reschke C; Bandy D; Alexander GE; Caselli RJ
    Neuroimage; 2010 Jan; 49(1):169-76. PubMed ID: 19631758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease.
    Reiman EM; Caselli RJ; Chen K; Alexander GE; Bandy D; Frost J
    Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3334-9. PubMed ID: 11248079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of APOE-ε4 allele load on brain morphology in a cohort of middle-aged healthy individuals with enriched genetic risk for Alzheimer's disease.
    Cacciaglia R; Molinuevo JL; Falcón C; Brugulat-Serrat A; Sánchez-Benavides G; Gramunt N; Esteller M; Morán S; Minguillón C; Fauria K; Gispert JD;
    Alzheimers Dement; 2018 Jul; 14(7):902-912. PubMed ID: 29605385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E-low density lipoprotein receptor interaction affects spatial memory retention and brain ApoE levels in an isoform-dependent manner.
    Johnson LA; Olsen RH; Merkens LS; DeBarber A; Steiner RD; Sullivan PM; Maeda N; Raber J
    Neurobiol Dis; 2014 Apr; 64():150-62. PubMed ID: 24412220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Affect of APOE on information processing speed in non-demented elderly population: a preliminary structural MRI study.
    Luo X; Jiaerken Y; Yu X; Huang P; Qiu T; Jia Y; Sun J; Zhou J; Zhang M;
    Brain Imaging Behav; 2017 Aug; 11(4):977-985. PubMed ID: 27444731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APOE-ε4 risk variant for Alzheimer's disease modifies the association between cognitive performance and cerebral morphology in healthy middle-aged individuals.
    Cacciaglia R; Molinuevo JL; Falcón C; Sánchez-Benavides G; Gramunt N; Brugulat-Serrat A; Esteller M; Morán S; Fauria K; Gispert JD;
    Neuroimage Clin; 2019; 23():101818. PubMed ID: 30991302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitively healthy APOE4/4 carriers show white matter impairment associated with serum NfL and amyloid-PET.
    Tato-Fernández C; Ekblad LL; Pietilä E; Saunavaara V; Helin S; Parkkola R; Zetterberg H; Blennow K; Rinne JO; Snellman A
    Neurobiol Dis; 2024 Mar; 192():106439. PubMed ID: 38365046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein E ε4 genotype status is not associated with neuroimaging outcomes in a large cohort of HIV+ individuals.
    Cooley SA; Paul RH; Fennema-Notestine C; Morgan EE; Vaida F; Deng Q; Chen JA; Letendre S; Ellis R; Clifford DB; Marra CM; Collier AC; Gelman BB; McArthur JC; McCutchan JA; Simpson DM; Morgello S; Grant I; Ances BM;
    J Neurovirol; 2016 Oct; 22(5):607-614. PubMed ID: 27021072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.